STMN1 and malignant pleural mesothelioma: Overexpression of miR-223 was capable to block myeloid cell proliferation through E2F1 inhibition [27] and miR-223 was described as a suppressor of cell proliferation in malignant pleural mesothelioma cells through STMN1 targeting [28].